2025-04-03 | EffePharm

NMNH is short for Reduced Nicotinamide Mononucleotide — the reduced form of NMN (β-Nicotinamide Mononucleotide). It basically signifies a major progress in NAD⁺ science by giving a way that is both faster and more efficient to restore NAD⁺ levels in the body. Since NMNH has a higher cellular uptake and conversion rate, it has been widely discussed in scientific research as well as in the longevity market.
Put simply, NMNH is a future-generation NAD⁺ precursor that makes the body physiologically healthier, the aging process stays healthy, and general well-being remains.
Both animal and human studies have indicated that NMNH supplements may outperform NMN in boosting NAD⁺ concentrations across vital organs such as the liver, brain, kidneys, and muscles. This discovery positions NMNH as one of the most promising NAD⁺ precursors for individuals seeking a safe and effective method to enhance mitochondrial health, sustain energy levels, and support longevity.
A frequent question in the supplement world is: “NMN vs NMNH — what is the real difference?”
The point that NMNH supplements are still generally considered to be more potent than NMN ones makes them very attractive to those who already have knowledge of NMN and want to find out more powerful versions. The question of NMN vs NMNH continues to be the most talked-about topic in the scientific community, but UthPeak® NMNH, with confirmed results from human studies, is winning this competition.
Multiple independent studies have demonstrated the remarkable efficacy of NMNH in raising NAD⁺ levels and improving cellular health:
These findings have positioned NMNH as a supplement with unique strengths, reinforcing its reputation as one of the best NMNH supplements available for energy and longevity support.
Study demonstrated that NMNH significantly increased NAD+ across various cell types and, in mice, led to a rapid and sustained NAD+ boost in key tissues like the liver, kidney, muscle, brain, and heart[1].
Another study from the National Library of Medicine reinforced these findings, showing a fivefold NAD+ increase in HepG2 cells. In mice, NMNH administration elevated liver NAD+ levels more effectively than NMN while maintaining a strong safety profile with no toxicity, even at high doses[2].
UthPeak® has conducted the world’s first, largest, and longest human clinical trial on NMNH (reduced NMN). This 90-day, double-blind, placebo-controlled study involved 80 healthy participants and assessed safety, efficacy, and overall well-being.
NAD+ Levels and Energy: The level of NAD+ in plasma was raised 3 times, a 35% increment in energy was reported, and fatigue was alleviated significantly.

Such results highlight why NMNH supplement reviews consistently praise UthPeak® as an industry leader.
UthPeak® NMNH is the first NMNH brand to conduct clinical studies, leading the world’s first, longest, and largest NMNH clinical trial. In the phase II clinical trial, our research aims to provide scientific validation of NMNH’s potential in promoting cellular health and longevity.
UthPeak® NMNH is one of the main contributors to the field of anti-aging research. It is the purest form of NMNH (reduced NMN) that directly alleviates the decrease in NAD+ levels due to aging and activates cellular repair and resistance. It has been a beacon of hope for raising NAD+ levels, which could lead to a better cell repair process, efficient metabolism, and general energy advancement.
UthPeak® NMNH sustains heart health through the healthy condition of blood vessels, the strength of the heart, and the ease of blood flow.
UthPeak® NMNH makes the function of the mitochondria stronger, ensuring a constant and enduring energy boost.
UthPeak® NMNH is a source of energy for neurons and consequently facilitates cognitive functions such as memory, focus, and clarity.
Through cellular health support and metabolic homeostasis, UthPeak® NMNH leads to better sleep quality, regulates sleep patterns, and maintains the normal state of sleep for restoring and restful sleep.
Contact us to learn more about the NMNH benefits.
With the popularity of NMNH (Reduced NMN), people are paying more attention to its safety. As a leader in the industry, UthPeak® NMNH also upholds the sense of responsibility for consumer safety. Since 2023, we have been focusing on the safety testing of NMNH.

UthPeak® continues to pioneer in safety testing and transparency, making it the trusted choice for anyone comparing NMN vs NMNH.
For further details on NMNH and its potential benefits.
Reference
[1]Rubén Zapata-Pérez, Alessandra Tammaro. Reduced nicotinamide mononucleotide is a new and potent NAD+ precursor in mammalian cells and mice. The FASEB Journal. 16 March. 2021. https://doi.org/10.1096/fj.202001826R
[2]Yan Liu, Chengting Luo et al. (2021). Reduced Nicotinamide Mononucleotide (NMNH) Potently Enhances NAD+ and Suppresses Glycolysis, the TCA Cycle, and Cell Growth. J Proteome Res. 2021 May 7;20(5):2596-2606. doi: 1021/acs.jproteome.0c01037. Epub 2021 Apr 1
Reference available upon request.
| These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. |
Information on this site is provided for informational purposes only. It is not meant to substitute for medical advice from your physician or other medical professional. You should not use the information contained herein to diagnose or treat a health problem or disease or prescribe any medication. Carefully read all product documentation. If you have or suspect that you have a medical problem, promptly contact your regular healthcare provider.